Colorado Physician Ebook Continuing Education

Table 11: Oral Opioids for Acute Pain in Opioid-Naïve Adults Medication Available Oral Strengths Dosage

Clinical Considerations

Hydrocodone, extended-release tablets • Zohydro ER

Tablets: 10 mg 15 mg 20 mg 30 mg 40 mg 50 mg

Initiate: • 10 mg every 12 hours • Titrate by 10 mg

The conversion factor for daily oral opioids to Zohydro: • Hydrocodone: 1

• Oxycodone: 1 • Methadone: 1 • Oxymorphone: 2 • Hydromorphone: 2.67 • Morphine: 0.67 • Codeine: 0.1

every 12 hours as needed every 7 to 10 days

Do not use it to convert Zohydro to other opioids, as it will result in overestimation and possible fatal overdose. During treatment with extended-release formulations, immediate-release formulations may be required for breakthrough pain. Conversion factor for daily oral opioids to Hysingia: • Hydrocodone: 1 • Oxycodone: 1

Hydrocodone, extended-release tablets • Hysingia ER

Tablets: 20 mg 30 mg 40 mg 60 mg 80 mg 100 mg 120 mg

Initiate: • 20 mg every 24 hours • Titrate dose by 10 to 20 mg every 3 to 4 days as needed

• Methadone: 1.5 • Oxymorphone: 2 • Hydromorphone: 4

• Morphine: 0.5 • Codeine: 0.15 • Tramadol: 0.1

Do not use it to convert Hysingia to other opioids, as this will result in overestimation and possible fatal overdose. During treatment with extended-release formulations, immediate-release formulations may be required for breakthrough pain. In opioid-tolerant patients, the dose and duration of pain relief will vary depending on the patient’s tolerance. Commonly used for breakthrough pain in patients receiving around-the-clock hydromorphone. The conversion factor for daily oral opioids to Exalgo: • Hydromorphone: 1 • Codeine: 0.06 • Hydrocodone: 0.4 • Methadone: 0.6 • Oxycodone: 0.4 • Oxymorphone: 0.6 Do not use to convert Exalgo to other opioids, as this will result in overestimation and possible fatal overdose. During treatment with extended-release formulations, immediate-release formulations may be required for breakthrough pain.

Hydromorphone, immediate release

Tablets: 2 mg 4 mg 8 mg Oral solution: 5 mg/5 mL

As the first opioid or in patients not opioid tolerant: • Tablets: 2 to 4 mg PO every 4 to 6 hours • Oral solution: 2.5 to 10 mg PO every 3 to 6 hours Conversion from immediate release hydromorphone: • Calculate total daily hydromorphone dose and give orally once daily • Titrate dose by 4 to 8 mg every 3 to 4 days as needed

Hydromorphone, extended-release tablets • Exalgo

Tablets: 8 mg

12 mg 16 mg 32 mg

Book Code: MDCO1025

Page 71

Powered by